What is the global market size of Influenza Diagnostics Market?

Influenza Diagnostics Market size was valued at USD 1.07 billion in 2021 and is poised to grow from USD 1.1 billion in 2022 to USD 1.46 billion by 2030, growing at a CAGR of 3.5% in the forecast period (2023-2030).

Global Influenza Diagnostics Market Size, Share, Growth Analysis, By Test Type(Traditional Diagnostic Test, Molecular Diagnostic Assay), By End-User(Hospital, Laboratories) - Industry Forecast 2024-2031

Report ID: SQSG35G2011 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 62 | Figures: 75

Global Influenza Diagnostics Market News

In May 2022, The American pharmaceutical company announced that it has obtained Nod from the USFDA for the drug Aptima CMV Quant Assay for human cytomegalovirus. Use. And this could be a great development in reducing the adverse effect of the virus on humans.
In February 2022, Siemens Healthineers, in partnership with United Nations Children's Fund, today announced its contribution to strengthening health systems in the various African region by improving access to diagnostics and the link to treatment of major diseases.
In September 2021, Simplexa COVID-19 & Flu A/B Direct kit from DiaSorin Molecular LLC received the CE mark. The multiplex test allows for the in vitro qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, and influenza B virus from the same patient sample in a single reaction well.

Global Influenza Diagnostics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Influenza Diagnostics Market size was valued at USD 1.07 billion in 2019 and is poised to grow from USD 1.1 billion in 2023 to USD 1.46 billion by 2031, growing at a CAGR of 3.5% in the forecast period (2024-2031).

The Influenza Diagnostics Market is highly competitive, with the existence of numerous major firms operating in both domestic and international markets. The industry's top players are embracing strategic collaboration initiatives to improve market share and profitability. Some of the major players in the market are Becton Dickinson, Biomerieux, Merck, and Bio-Rad Laboratories among others who are driving the Influenza Diagnostics Market. 'Thermo Fisher Scientific, Inc.', 'Roche Diagnostics', 'Abbott Laboratories', 'Becton, Dickinson and Company', 'Quidel Corporation', 'DiaSorin S.p.A.', 'bioMérieux SA', 'Meridian Bioscience, Inc.', 'Luminex Corporation', 'Hologic, Inc.', 'F. Hoffmann-La Roche Ltd.', 'Cepheid Inc.', 'Sekisui Diagnostics LLC', 'GenMark Diagnostics, Inc.', 'Quanterix Corporation', 'Alere Inc.', 'Merck KGaA', 'Hologic, Inc.', 'Scienion AG', 'Enzo Biochem, Inc.'

The Human Genome Project and advances in molecular and biomedical technologies have resulted in the development of a plethora of assays and technologies useful for the diagnosis and management of influenza infections. These new technologies, which are based on genomic techniques (such as PCR) and proteomics (such as microarray detection), aid in the discovery of new influenza viruses. They also allow for better surveillance and rapid diagnosis of infectious diseases, which offers a Influenza Diagnostics Market opportunity.

Vaccination is a major method of immunizing individuals against infectious diseases to avoid serious complications, particularly in immunocompromised patients who are at high risk. Mutation of the virus serotype proves to be a major impediment because vaccination becomes difficult in such cases, putting the individual at risk of contracting the virus. Thus, as virus types change, it is critical to detect their presence in patients and administer timely medication to prevent fatalities. As a result, the demand for influenza diagnostics products has increased, accelerating market growth.

In 2021, North America dominated the influenza diagnostics market and it is expected to maintain its dominance throughout the forecast period (2022-2028). The regional Influenza Diagnostics Market is expected to be driven by the high prevalence of influenza during the forecast period. It is estimated that, approximately 5% to 20% of Americans will be diagnosed with influenza each year in 2022. Moreover, the Centers for Disease Control and Prevention reported 35 million flu-related illnesses, 380,000 flu-related hospitalizations, 20,000 flu-related deaths, and 16 million flu-related medical visits in 2019-2020. This rising disease burden is believed to have a positive impact on market growth in the coming years. RIDTs are widely available all across the region. The short time required to generate results is the reason for the test's wider availability. RIDT can produce results in as little as 15 minutes. With rising influenza-related hospitalizations and pediatric deaths, as well as government organizations' desire to better manage the disease, the North American influenza diagnostics market is expected to expand in the coming years.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Influenza Diagnostics Market Size, Share, Growth Analysis, By Test Type(Traditional Diagnostic Test, Molecular Diagnostic Assay), By End-User(Hospital, Laboratories) - Industry Forecast 2024-2031

Global Influenza Diagnostics Market News

Global Influenza Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Influenza Diagnostics Market?

Who are the key vendors in the Global Influenza Diagnostics Market?

What is the key driver of Global Influenza Diagnostics Market?

What is the key market trend for Global Influenza Diagnostics Market?

Which region accounted for the largest share in Global Influenza Diagnostics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300